S. A. Abzaliyeva, G. Junusbekova, I. Zhirov, G. K. Zhusupova, K. Abzaliyev, M.K. Tundybaeva, R. Bazarbekova, A.M. Raisova, A. Babenko, V. Ionin
{"title":"«SGLT2抑制剂：用于心力衰竭的基本原理»，国际参与专家小组的结果决议，阿拉木图","authors":"S. A. Abzaliyeva, G. Junusbekova, I. Zhirov, G. K. Zhusupova, K. Abzaliyev, M.K. Tundybaeva, R. Bazarbekova, A.M. Raisova, A. Babenko, V. Ionin","doi":"10.26577/iam.2022.v3.i2.08","DOIUrl":null,"url":null,"abstract":"1Al-Farabi Kazakh National University, Almaty, Kazakhstan 2 Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan 3 FSBI National Medical Research Center for Cardiology of the Ministry of Health of Russia, Moscow, Russia 4 Astana Medical University, Astana, Kazakhstan 5 Kazakh-Russian Medical University, Almaty, Kazakhstan 6Almazov National Medical Research Centre, Petersburg, Russia 7 First St. Petersburg state medical university. acad. I.P. Pavlova, St. Petersburg, Russia *e-mail: abzaliyeva.symbat@gmail.com","PeriodicalId":34543,"journal":{"name":"Interdisciplinary Approaches to Medicine","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"«SGLT2 INHIBITORS: RATIONALE FOR THE USE IN HEART FAILURE», RESOLUTION ON THE RESULTS OF THE PANEL OF EXPERTS WITH INTERNATIONAL PARTICIPATION, ALMATY\",\"authors\":\"S. A. Abzaliyeva, G. Junusbekova, I. Zhirov, G. K. Zhusupova, K. Abzaliyev, M.K. Tundybaeva, R. Bazarbekova, A.M. Raisova, A. Babenko, V. Ionin\",\"doi\":\"10.26577/iam.2022.v3.i2.08\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"1Al-Farabi Kazakh National University, Almaty, Kazakhstan 2 Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan 3 FSBI National Medical Research Center for Cardiology of the Ministry of Health of Russia, Moscow, Russia 4 Astana Medical University, Astana, Kazakhstan 5 Kazakh-Russian Medical University, Almaty, Kazakhstan 6Almazov National Medical Research Centre, Petersburg, Russia 7 First St. Petersburg state medical university. acad. I.P. Pavlova, St. Petersburg, Russia *e-mail: abzaliyeva.symbat@gmail.com\",\"PeriodicalId\":34543,\"journal\":{\"name\":\"Interdisciplinary Approaches to Medicine\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Interdisciplinary Approaches to Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.26577/iam.2022.v3.i2.08\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Interdisciplinary Approaches to Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.26577/iam.2022.v3.i2.08","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
«SGLT2 INHIBITORS: RATIONALE FOR THE USE IN HEART FAILURE», RESOLUTION ON THE RESULTS OF THE PANEL OF EXPERTS WITH INTERNATIONAL PARTICIPATION, ALMATY
1Al-Farabi Kazakh National University, Almaty, Kazakhstan 2 Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan 3 FSBI National Medical Research Center for Cardiology of the Ministry of Health of Russia, Moscow, Russia 4 Astana Medical University, Astana, Kazakhstan 5 Kazakh-Russian Medical University, Almaty, Kazakhstan 6Almazov National Medical Research Centre, Petersburg, Russia 7 First St. Petersburg state medical university. acad. I.P. Pavlova, St. Petersburg, Russia *e-mail: abzaliyeva.symbat@gmail.com
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
